Please assess the completion status of the following clinical trial:

Trial Title: The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age and older~* Subjects has actinic keratoses and qualifies for photodynamic therapy~* Do not meet any of the exclusion criteria~Exclusion Criteria:~* Subjects who smoke~* Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition~* Subjects who have established allergy to topical ALA~* Subjects who have had a documented nonmelanoma skin cancer on the face over the past 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 10-minute Incubation with Microneedle Roller & Sham (Type: EXPERIMENTAL): 10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.
- 20-minute Incubation with Microneedle Roller & Sham (Type: EXPERIMENTAL): 20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

Based on this trial design, predict the completion outcome and termination type (if applicable).